Company profile
Lexaria Bioscience Corp.
NASDAQ:LEXXBiotechnology: Pharmaceutical Preparations
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT06648031 | phase1 | completed | 2024-12-04 | 2025-07-31 | Lexaria Bioscience Corp. | Comparison of the Safety, Efficacy and Pharmacokinetics of DehydraTECH -CBD and DehydraTECH-GLP1 Agonists Alone or in Combination, in Overweight or Obese, Pre- and Type 2 Diabetic Participants |
FDA applications (0)
No records yet.